ILA's Principal Activity is the drug research and repurposing
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -57.31% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Island Pharmaceuticals Limited (ILA) is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. Its lead product candidate is Isla101 for the treatment and/or prevention of mosquito borne viruses, such as dengue fever.
No incorporation details available.
Head Office | Camberwell VIC 3124 |
Website | www.islandpharmaceuticals.com |
Registry | Automic Group |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 13 Apr 2021 |
Date | Event |
---|---|
25/08/2022 | Report (Prelim) |
25/08/2022 | Report (Annual) |
13/10/2022 | Report (Annual) |
23/02/2023 | Report (Interim) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
ILA directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of ILA directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
KESA PARTNERS INC | 13/08/2021 | 10,837,367 | 13.38 |
David Charles Foster | 13/08/2021 | 5,146,829 | 6.63 |
William James Garner | 19/08/2021 | 21,913,098 | 27.06 |
Jason Alan Carroll | 28/04/2022 | 9,900,000 | 12.18 |
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
28-04-22 | Jason Alan Carroll | 814,391 | 11.17 | 12.18 |
29-03-22 | Jason Alan Carroll | 835,609 | 10.15 | 11.17 |
01-02-22 | Jason Alan Carroll | 950,000 | 9.00 | 10.15 |
25-11-21 | Jason Alan Carroll | 1,625,000 | 7.00 | 9.00 |
19-10-21 | Jason Alan Carroll | 800,000 | 6.00 | 7.00 |
13-10-21 | Jason Alan Carroll | 825,000 | 5.00 | 6.00 |
19-08-21 | William James Garner | 822,493 | 26.05 | 27.06 |
11-08-21 | Jason Alan Carroll | 4,050,000 | -- | 5.00 |
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.268 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.